Systematic review of the influence of spasticity on quality of life in adults with chronic neurological conditions

Disability and Rehabilitation

Volumn 38, Issue 15, 2016, Pages 1431-1441

  Milinis, K ^a,b   Young, C A ^a,b  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b THE WALTON CENTRE NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Multiple sclerosis; quality of life; spasticity; spinal cord injury; stroke

Indexed keywords

EID: 84951871684     PISSN: 09638288     EISSN: 14645165     Source Type: Journal    
DOI: 10.3109/09638288.2015.1106592     Document Type: Review

References (52)

1. Pandyan AD, Gregoric M, Barnes MP, et al. Spasticity: clinical perceptions, neurological realities and meaningful measurement. Disabil Rehabil. 2005;27:2-6.
2. Rizzo MA, Hadjimichael OC, Preiningerova J, et al. Prevalence and treatment of spasticity reported by multiple sclerosis patients. Mult Scler. 2004;10:589-595.
3. Barnes MP, Kent RM, Semlyen JK, et al. Spasticity in multiple sclerosis. Neurorehabil Neural Repair. 2003; 17:66-70.
4. Zorowitz RD, Gillard PJ, Brainin M. Poststroke spasticity: sequelae and burden on stroke survivors and caregivers. Neurology. 2013;80:S45-S52.
5. Shakespeare DT, Boggild M, Young C. Anti-spasticity agents for multiple sclerosis. Cochrane Database Syst Rev. 2003;CD001332.
6. Paisley S, Beard S, Hunn A, et al. Clinical effectiveness of oral treatments for spasticity in multiple sclerosis: A systematic review. Mult Scler. 2002;8:319-329.
7. Zwibel HL. Contribution of impaired mobility and general symptoms to the burden of multiple sclerosis. Adv Ther. 2009;26:1043-1057.
8. Schinwelski M, Slawek J. Prevalence of spasticity following stroke and its impact on quality of life with emphasis on disability in activities of daily living. Systematic review. Neurol Neurochir Pol. 2010;44:404-411.
9. Doan QV, Brashear A, Gillard PJ, et al. Relationship between disability and health-related quality of life and caregiver burden in patients with upper limb poststroke spasticity. PMR. 2012;4:4-10.
10. Martin A, Abogunrin S, Kurth H, et al. Epidemiological, humanistic, and economic burden of illness of lower limb spasticity in adults: A systematic review. Neuropsychiatr Dis Treat. 2014;10:111-122.
11. Berger T. Multiple sclerosis spasticity daily management: retrospective data from Europe. Exp Rev Neurotherap. 2013;13:3-7.
12. Ford HL, Gerry E, Johnson MH, et al. Health status and quality of life of people with multiple sclerosis. Disabil Rehabil. 2001;23:516-521.
13. Smith KW, Avis NE, Assmann SF. Distinguishing between quality of life and health status in quality of life research: A meta-analysis. Qual Life Res. 1999;8:447-459.
14. Ferrans CE. Quality of life: conceptual issues. Semin Oncol Nurs. 1990;6:248-254.
15. Burns TM, Graham CD, Rose MR, et al. Quality of life and measures of quality of life in patients with neuromuscular disorders. Muscle Nerve. 2012;46:9-25.
16. Bradley C. Importance of differentiating health status from quality of life. Lancet. 2001;357:7-8.
17. Flachenecker P, Henze T, Zettl UK. Spasticity in patients with multiple sclerosis-clinical characteristics, treatment and quality of life. Acta Neurol Scand. 2014; 129:154-162.
18. Gillard SSH, Alwell, K. The Negative Impact of Spasticity on the Health-Related Quality of Life of Stroke Survivors. Stroke, International Stroke Conference 2005.
19. von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370:1453-1457.
20. Wu N, Minden SL, Hoaglin DC, et al. Quality of life in people with multiple sclerosis: data from the Sonya Slifka Longitudinal Multiple Sclerosis Study. J Health Hum Serv Adm. 2007;30:233-267.
21. Arroyo R, Massana M, Vila C. Correlation between spasticity and quality of life in patients with multiple sclerosis: The CANDLE study. Int J Neurosci. 2013;123: 850-858.
22. Svensson J, Borg S, Nilsson P. Costs and quality of life in multiple sclerosis patients with spasticity. Acta Neurol Scand. 2014;129:13-20.
23. Westgren N, Levi R. Quality of life and traumatic spinal cord injury. Arch Phys Med Rehabil. 1998;79:1433-1439.
24. Post MW, de Witte LP, van Asbeck FW, et al. Predictors of health status and life satisfaction in spinal cord injury. Arch Phys Med Rehabil. 1998;79:395-401.
25. Vogel LC, Krajci KA, Anderson CJ. Adults with pediatriconset spinal cord injuries: part 3: impact of medical complications. J Spinal Cord Med. 2002;25:297-305.
26. Singh R, Dhankar SS, Rohilla R. Quality of life of people with spinal cord injury in Northern India. Int J Rehabil Res. 2008;31:247-251. 10.1097/MRR.0b013e3282fb7d25.
27. Westerkam D, Saunders LL, Krause JS. Association of spasticity and life satisfaction after spinal cord injury. Spinal Cord. 2011;49:990-994.
28. Noonan VK, Kopec JA, Zhang H, et al. Impact of associated conditions resulting from spinal cord injury on health status and quality of life in people with traumatic central cord syndrome. Arch Phys Med Rehabil. 2008;89: 1074-1082.
29. Urban PP, Wolf T, Uebele M, et al. Occurence and clinical predictors of spasticity after ischemic stroke. Stroke. 2010;41:2016-2020.
30. Wissel J, Schelosky LD, Scott J, et al. Early development of spasticity following stroke: A prospective, observational trial. J Neurol. 2010;257:1067-1072.
31. Welmer AK, von Arbin M, Widen Holmqvist L, et al. Spasticity and its association with functioning and healthrelated quality of life 18 months after stroke. Cerebrovasc Dis. 2006;21:247-253.
32. Dajpratham P, Kuptniratsaikul V, Kovindha A, et al. Prevalence and management of poststroke spasticity in Thai stroke patients: A multicenter study. J Med Assoc Thai. 2009;92:1354-1360.
33. Ones K, Yilmaz E, Cetinkaya B, et al. Quality of life for patients poststroke and the factors affecting it. J Stroke Cerebrovasc Dis. 2005;14:261-266.
34. Arroyo R, Vila C, Clissold S. Retrospective observational study of the management of multiple sclerosis patients with resistant spasticity in Spain: The '5E' study. Expert Rev Pharmacoecon Outcomes Res. 2011;11:205-213.
35. Sommerfeld DK, Eek EU, Svensson AK, et al. Spasticity after stroke: its occurrence and association with motor impairments and activity limitations. Stroke. 2004;35:134-139.
36. Oreja-Guevara CGD, Vila, C, de Sola, S. Multiple sclerosis spasticity in Spain: The 6E patients' survey. 5th Joint triennial congress of the European and Americas Committees for Treatment and Research in Multiple Sclerosis Amsterdam, the Netherlands; 2011.
37. Mahoney JS, Engebretson JC, Cook KF, et al. Spasticity experience domains in persons with spinal cord injury. Arch Phys Med Rehabil. 2007;88:287-294.
38. Nicolson P, Anderson P. The psychosocial impact of spasticityrelated problems for people with multiple sclerosis: A focus group study. J Health Psychol. 2001;6:551-567.
39. Morley A, Tod A, Cramp M, et al. The meaning of spasticity to people with multiple sclerosis: what can health professionals learn? Disabil Rehabil. 2013;35:1284-1292.
40. Lundstrom E, Terent A, Borg J. Prevalence of disabling spasticity 1 year after first-ever stroke. Eur J Neurol. 2008;15:533-539.
41. Ferrans CE, Zerwic JJ, Wilbur JE, et al. Conceptual model of health-related quality of life. J Nurs Scholarsh. 2005;37:336-342.
42. Schipper H, Clinch JJ, Olweny CLM. Quality of life studies: definitions and conceptual issues. In: Spiler B, editor. Quality of life and pharmacoeconomics in clinical trials. Philadelphia (PA): Lippincott-Raven; 1996. p. 11-23.
43. Ferrans CE. Differences in what quality-of-life instruments measure. J Natl Cancer Inst Monogr. 2007;22-26.
44. Huang IC, Wu A, Frangakis C. Do the SF-36 and WHOQOLBREF Measure the Same Constructs? Evidence from the Taiwan Population. Qual Life Res. 2006;15:15-24.
45. Wilson IB, Cleary PD. Linking clinical variables with healthrelated quality of life. A conceptual model of patient outcomes. JAMA. 1995;273:59-65.
46. Benito-Leon J, Morales JM, Rivera-Navarro J, et al. A review about the impact of multiple sclerosis on health-related quality of life. Disabil Rehabil. 2003;25:1291-1303.
47. Baumstarck K, Reuter F, Boucekine M, et al. Relevance of quality of life assessment for multiple sclerosis patients with memory impairment. PLoS One. 2012;7:e50056.
48. Hobart JC, Freeman J, Lamping D, et al. The SF-36 in multiple sclerosis: why basic assumptions must be tested. J Neurol Neurosurg Psychiatry. 2001;71:363-370.
49. Pandyan AD, Johnson GR, Price CI, et al. A review of the properties and limitations of the Ashworth and modified Ashworth Scales as measures of spasticity. Clin Rehabil. 1999;13:373-383.
50. Fleuren JF, Voerman GE, Erren-Wolters CV, et al. Stop using the Ashworth Scale for the assessment of spasticity. J Neurol Neurosurg Psychiatry. 2010;81:46-52.
51. Burridge JH, Wood DE, Hermens HJ, et al. Theoretical and methodological considerations in the measurement of spasticity. Disabil Rehabil. 2005;27:69-80.
52. Hobart JC, Riazi A, Thompson AJ, et al. Getting the measure of spasticity in multiple sclerosis: The Multiple Sclerosis Spasticity Scale (MSSS-88). Brain. 2006;129:224-234.